Reports

New start-up companies are constantly commercialising new technologies and services. Genomics is ripe for investment right now.

UC Berkeley look to subpoena George Church as part of on-going CRISPR patent dispute

Merja Mehto from Thermo Fisher Scientific takes us through the intricacies of sample preparation, the crucial first step in molecular science

How can young scientists make the leap from academia to business? BioMed Central’s Dana Berry takes a look at life as a biotech entrepreneur

Scientists have begun to move into the £650 million Francis Crick Institiute in London and take up residence in their new labs

What underlies disruptive scientific advancement? Marc Hogenbirk of Bluebee makes the case that many advances are driven by the availability of data

Rumours: whether you’re spreading them, or just listening to the legendary Fleetwood Mac album, we have the roundup for you

A new world of genomic research, featuring Atul Butte, Roger Lasken, Stephen Kingsmore, and the genomics capital of the world

Consortium gathers in San Diego to create new paths to identifying currently undiagnosed illnesses

Patent litigation is a costly process, but according to STAT News, the sums involved in the CRISPR dispute are soaring

Vast stores of available data and outsourced research are simply waiting for the right questions, says Atul Butte

Apple’s Senior Vice President of Worldwide Marketing joins Illumina on the Board of Directors

Let us take you on a cheeky coffee break with some of the best bits from down the back of the internet sofa. Who knows, there might even be cake…

How can consumers learn more about their genome while still having complete control of their data?

The new CEO at Helix gave us his take on creating the world’s first personal genomics platform

In the wake of yet more clinical trial deaths, Rebecca Robbins explores the impact on patients for STAT News